Expand CDT Menu
CDT MENU

CDT Latest Press Releases

-- May 28, 2026 --

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter Globe Newswire 4:15 PM

-- May 27, 2026 --

CDT Announces Canadian Patent for AZD5904 in Male Infertility Globe Newswire 8:00 AM

-- May 7, 2026 --

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market Globe Newswire 8:30 AM

-- May 6, 2026 --

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions Globe Newswire 8:30 AM

-- April 16, 2026 --

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery Globe Newswire 8:30 AM

-- April 7, 2026 --

CDT Notes Sarborg Publication of PRISM Framework Expanding AI Globe Newswire 8:30 AM

-- March 26, 2026 --

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings Globe Newswire 8:30 AM

-- March 25, 2026 --

CDT Equity Inc. Announces Reverse Stock Split Globe Newswire 8:00 AM

-- March 23, 2026 --

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy Globe Newswire 8:30 AM

-- March 18, 2026 --

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth Globe Newswire 8:30 AM

-- March 12, 2026 --

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence Globe Newswire 8:30 AM

-- March 5, 2026 --

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent Globe Newswire 8:30 AM

-- March 4, 2026 --

CDT Positions for Transformational Growth Globe Newswire 8:30 AM

-- February 20, 2026 --

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy Globe Newswire 8:30 AM

-- January 2, 2026 --

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes